Industry News
FDA Approves Postpartum Depression Drug Zulresso, But Concerns Arise Over Cost
In mid-March, the FDA approved the postpartum depression drug brexanolone,
April 2, 2019 No Comments
Tag: sage therapeutics
Read More »
In mid-March, the FDA approved the postpartum depression drug brexanolone,